CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

Authors: Wang Y, Liu C, Gao S, Wang B, Wang H, Shi Z, Xia S, Li J, Yao X, Guo X, Zheng J, Zhou Q, Chen Z, Zheng L, Zhang Q, Du J, Zhou T, Zhang Z, Song W, Qi L, Wang Y, Sher YP, Li M, Zhou X, Hung MC, Ren Y, Hao J

Journal: Nature communications